These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 21536811)

  • 1. Invitation strategies and coverage in the population-based cancer screening programmes in the European Union.
    Vale DB; Anttila A; Ponti A; Senore C; Sankaranaryanan R; Ronco G; Segnan N; Tomatis M; Žakelj MP; Elfström KM; Lönnberg S; Dillner J; Basu P
    Eur J Cancer Prev; 2019 Mar; 28(2):131-140. PubMed ID: 29570103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent participation in screening for cervical, breast, and bowel cancer in England.
    Rebolj M; Parmar D; Maroni R; Blyuss O; Duffy SW
    J Med Screen; 2020 Mar; 27(1):9-17. PubMed ID: 31525303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs.
    Armstrong K; Kim JJ; Halm EA; Ballard RM; Schnall MD
    Cancer; 2016 May; 122(9):1338-42. PubMed ID: 26929386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of changes to invite methodology on equality of access to the National Breast Screening Programme in the South of England.
    Westrop SJ; Thomas A; Williams A; Johnson F; Liao H; Edlin K; Burgess K; Kearins O; Maclean R
    J Med Screen; 2024 Jun; 31(2):115-118. PubMed ID: 38105465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening.
    Beaber EF; Kim JJ; Schapira MM; Tosteson AN; Zauber AG; Geiger AM; Kamineni A; Weaver DL; Tiro JA;
    J Natl Cancer Inst; 2015 Jun; 107(6):djv120. PubMed ID: 25957378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An ongoing case-control study to evaluate the NHS Bowel Cancer Screening Programme.
    Massat NJ; Sasieni PD; Parmar D; Duffy SW
    BMC Cancer; 2014 Dec; 14():945. PubMed ID: 25495609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The New Submission Process: Making a List and Checking It Twice.
    Mont MA; Bowen ET; Liu SS; Backstein DJ; Bellamy JL; Browne JA; Jones LC; Krebs VE; Mason JB; Taunton MJ; Tsao AK
    J Arthroplasty; 2022 Oct; 37(10):1895. PubMed ID: 36162921
    [No Abstract]   [Full Text] [Related]  

  • 8. What affects response rates in primary healthcare-based programmes? An analysis of individual and unit-related factors associated with increased odds of non-response based on HCV screening in the general population in Poland.
    Parda N; Stępień M; Zakrzewska K; Madaliński K; Kołakowska A; Godzik P; Rosińska M
    BMJ Open; 2016 Dec; 6(12):e013359. PubMed ID: 27927665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening.
    Smith RA; Brooks D; Cokkinides V; Saslow D; Brawley OW
    CA Cancer J Clin; 2013; 63(2):88-105. PubMed ID: 23378235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer screening in the primary care setting: the role of the primary care physician in screening for breast, cervical, colorectal, lung, ovarian, and prostate cancers.
    Miser WF
    Prim Care; 2007 Mar; 34(1):137-67. PubMed ID: 17481991
    [No Abstract]   [Full Text] [Related]  

  • 11. Avoiding inappropriate invitations to cancer screening programmes: the role of primary care.
    Campbell C; Anandan C; Appleton S; Elton R; Patnick J; Weller D
    J Med Screen; 2011; 18(1):12-7. PubMed ID: 21536811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of UK colorectal cancer screening pilot on primary care.
    Jepson R; Weller D; Alexander F; Walker J
    Br J Gen Pract; 2005 Jan; 55(510):20-5. PubMed ID: 15667761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Approach to population-based screening in the Czech Republic, methodology and first results of the personalised invitation of citizens to cancer screening programmes].
    Dušek L; Májek O; Bláha M; Daneš J; Zavoral M; Seifert B; Dvořák V; Skovajsová M; Suchánek S; Jung T; Brzková M; Klika P; Klimeš D; Koptíková J; Gregor J
    Klin Onkol; 2014; 27 Suppl 2():59-68. PubMed ID: 25494890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Performance indicators in screening programmes].
    Májek O; Ngo O; Daneš J; Zavoral M; Dvořák V; Klimeš D; Dušek L
    Klin Onkol; 2014; 27 Suppl 2():106-12. PubMed ID: 25494895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary care practice and facility quality orientation: influence on breast and cervical cancer screening rates.
    Goldzweig CL; Parkerton PH; Washington DL; Lanto AB; Yano EM
    Am J Manag Care; 2004 Apr; 10(4):265-72. PubMed ID: 15124503
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.